← Back to Search

Web-Based Program for Body Image After Head and Neck Cancer Treatment (BIHNC Trial)

N/A
Waitlist Available
Led By Bethany Rhoten, PhD
Research Sponsored by Bethany Rhoten
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Undergoing head and neck cancer treatment at time of study enrollment
Cognitive impairment that would preclude ability to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial tests an online program to help people who have finished head and neck cancer treatment feel better about their body image. The program includes educational lessons and personal reflection activities. It aims to see if the program is feasible, acceptable, and effective in improving body image.

Who is the study for?
This trial is for individuals who finished head and neck cancer treatment between 3-24 months ago, are unhappy with their body's appearance or function post-treatment, and have significant body image concerns (BIS score > 10). It excludes those with cognitive impairments, inability to read computer text, non-English speakers, or anyone still in cancer treatment.
What is being tested?
The study tests a six-week online program called BIHNC designed to help survivors of head and neck cancers. The program includes educational modules and personal reflection activities aimed at improving participants' body image.
What are the potential side effects?
Since the interventions are psychoeducational rather than medical treatments, traditional side effects like you'd see with medication aren't expected. Participants may experience emotional discomfort while reflecting on their body image.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently receiving treatment for head and neck cancer.
Select...
I am able to understand and make decisions about my health care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: Body Image after Head and Neck Cancer TreatmentExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
e-learning didactic module
2021
N/A
~10
Personal reflection activities
2021
N/A
~10

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Head and Neck Cancers include surgery, radiotherapy, chemotherapy, and targeted therapy. Surgery involves the physical removal of the tumor, which is crucial for eliminating cancerous cells. Radiotherapy uses high-energy radiation to destroy cancer cells and shrink tumors, while chemotherapy employs drugs to kill rapidly dividing cancer cells throughout the body. Targeted therapy focuses on specific molecules involved in cancer growth, offering a more precise treatment approach. These treatments are essential for controlling and potentially curing the cancer. Additionally, psychoeducation and personal reflection, as studied in the Body Image after Head and Neck Cancer Treatment Program, play a significant role in helping patients cope with the psychological and emotional impacts of their treatment, improving their overall quality of life and aiding in their recovery.
Patients' and health professionals' experience of the Danish fast track treatment pathway for head and neck cancer patients receiving oral rehabilitation.Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013.Integration of prospective quality of life and nutritional assessment as routine components of multidisciplinary care of patients with head and neck cancer.

Find a Location

Who is running the clinical trial?

Bethany RhotenLead Sponsor
Bethany Rhoten, PhDPrincipal Investigator - Vanderbilt Medical Center
Vanderbilt-Ingram Cancer Center
1 Previous Clinical Trials

Media Library

Personal reflection activities Clinical Trial Eligibility Overview. Trial Name: NCT04830488 — N/A
Head and Neck Cancers Research Study Groups: Body Image after Head and Neck Cancer Treatment
Head and Neck Cancers Clinical Trial 2023: Personal reflection activities Highlights & Side Effects. Trial Name: NCT04830488 — N/A
Personal reflection activities 2023 Treatment Timeline for Medical Study. Trial Name: NCT04830488 — N/A
~2 spots leftby Oct 2025